Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
Clinical trial NCT02252016 · COMPLETED
Trial details
- NCT number
- NCT02252016
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-22
- Primary completion
- 2015-12-07
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.